Ken Griffin
IMUX icon

Ken Griffin’s Immunic IMUX Stock Holding History

Ken Griffin’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$127K Sell
11,449
-15,232
-57% -$136K ﹤0.01% 11827
2025
Q4 		$142K Sell
26,681
-26,827
-50% -$197K ﹤0.01% 11362
2025
Q3 		$472K Buy
+53,508
New +$472K ﹤0.01% 9273
2025
Q1 		– Sell
-30
Closed -$324 – 14994
2024
Q4 		$300 Sell
30
-23,976
-100% -$302K ﹤0.01% 14350
2024
Q3 		$396K Buy
+24,006
New +$342K ﹤0.01% 8739
2024
Q2 		– Hold
0
– – – 14126
2024
Q1 		– Hold
0
– – – 14464
2023
Q3 		– Sell
-188
Closed -$3.61K – 14661
2023
Q2 		$4.72K Sell
188
-610
-76% -$10.2K ﹤0.01% 13574
2023
Q1 		$11.9K Sell
798
-1,722
-68% -$32K ﹤0.01% 13450
2022
Q4 		$35.3K Buy
+2,520
New +$68.7K ﹤0.01% 12556
2022
Q3 		– Sell
-49,655
Closed -$2.08M – 13080
2022
Q2 		$1.72M Buy
49,655
+46,217
+1,344% +$2.96M ﹤0.01% 5849
2022
Q1 		$389K Sell
3,438
-1,023
-23% -$118K ﹤0.01% 9977
2021
Q4 		$427K Buy
+4,461
New +$402K ﹤0.01% 10060
2021
Q3 		– Sell
-1,391
Closed -$137K – 14208
2021
Q2 		$171K Buy
+1,391
New +$192K ﹤0.01% 12354
2021
Q1 		– Sell
-2,313
Closed -$392K – 13439
2020
Q4 		$353K Sell
2,313
-497
-18% -$89.3K ﹤0.01% 8780
2020
Q3 		$522K Buy
+2,810
New +$460K ﹤0.01% 7227
2019
Q2 		– Sell
-144
Closed -$11K – 9498
2019
Q1 		$11K Sell
144
-33
-19% -$2.9K ﹤0.01% 9145
2018
Q4 		$13K Sell
177
-565
-76% -$66.1K ﹤0.01% 8868
2018
Q3 		$82K Buy
742
+653
+734% +$1.7M ﹤0.01% 8648
2018
Q2 		$245K Buy
+89
New +$206K ﹤0.01% 7551
2018
Q1 		– Sell
-96
Closed -$229K – 8512
2017
Q4 		$229K Buy
+96
New +$212K ﹤0.01% 6899
2016
Q1 		– Sell
-53
Closed -$246K – 7320
2015
Q4 		$246K Buy
+53
New +$173K ﹤0.01% 5514
2015
Q3 		– Sell
-11
Closed -$55K – 9044
2015
Q2 		$92K Buy
+11
New +$105K ﹤0.01% 7154

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Ken Griffin's IMUX Position: Q1 2026 in Review

Ken Griffin reduced its Immunic (IMUX) stake by 57% in Q1 2026, selling an estimated $136K and leaving 11,449 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #11827.

Ken Griffin first reported a position in IMUX in Q2 2015 and has held it in 21 quarters since. The position peaked at $1.72M in Q2 2022. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

  • Ken Griffin held 11,449 shares of Immunic worth $127K as of Q1 2026.
  • Ken Griffin sold 15,232 Immunic shares in Q1 2026, an estimated $136K.
  • Immunic made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #11827 holding.
  • Ken Griffin first reported a position in Immunic in Q2 2015 and has held it in 21 quarters since.
  • Ken Griffin's Immunic position peaked at $1.72M in Q2 2022.
  • 75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.